We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+3.27%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$7.23B
AUM Growth
+$298M
(+4.3%)
Cap. Flow
+$149M
Cap. Flow
% of AUM
2.07%
Top 10 Holdings %
Top 10 Hldgs %
15.39%
Holding
1,100
New
151
Increased
415
Reduced
333
Closed
164
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$40.6M |
| 2 |
Autodesk
ADSK
|
+$38.8M |
| 3 |
Intuit
INTU
|
+$37.1M |
| 4 |
Ecolab
ECL
|
+$35.6M |
| 5 |
Coca-Cola
KO
|
+$35.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$51.9M |
| 2 |
EOG Resources
EOG
|
+$33.8M |
| 3 |
DATA
Tableau Software, Inc.
DATA
|
+$32M |
| 4 |
Microsoft
MSFT
|
+$29.8M |
| 5 |
Ford
F
|
+$29.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.67% |
| 2 | Financials | 17.68% |
| 3 | Consumer Discretionary | 13.74% |
| 4 | Industrials | 11.53% |
| 5 | Healthcare | 11.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
726
Covenant Logistics
CVLG
$1.18B
| $550K | 0.01% |
74,724
-660
| -0.9% | -$5.78K |
|
|
DERM
727
DELISTED
Dermira, Inc.
DERM
| $550K | 0.01% |
57,563
-706,027
| -92% | -$7.6M |
|
728
Jones Lang LaSalle
JLL
$15.1B
| $549K | 0.01% |
+3,902
| New | +$555K |
|
729
Shenandoah Telecom
SHEN
$632M
| $549K | 0.01% |
14,260
| – | – |
|
730
Provident Financial Services
PFS
$3.11B
| $545K | 0.01% |
22,459
+4,430
| +25% | +$112K |
|
731
Marten Transport
MRTN
$1.33B
| $532K | 0.01% |
44,007
-23,522
| -35% | -$294K |
|
732
First Business Financial Services
FBIZ
$562M
| $529K | 0.01% |
22,503
+3,780
| +20% | +$85.8K |
|
733
Inseego
INSG
$108M
| $524K | 0.01% |
10,940
| – | – |
|
734
Peoples Bancorp
PEBO
$1.45B
| $524K | 0.01% |
16,245
+3,230
| +25% | +$103K |
|
|
NTGN
735
DELISTED
Neon Therapeutics, Inc. Common Stock
NTGN
| $524K | 0.01% |
110,561
-24,032
| -18% | -$135K |
|
736
Merchants Bancorp
MBIN
$2.19B
| $522K | 0.01% |
45,978
-3,564
| -7% | -$48.8K |
|
737
Corpay
CPAY
$24.2B
| $511K | 0.01% |
1,820
+580
| +47% | +$152K |
|
|
HALL
738
DELISTED
Hallmark Financial Services, Inc.
HALL
| $509K | 0.01% |
3,575
+532
| +17% | +$63.5K |
|
|
TBNK
739
DELISTED
Territorial Bancorp Inc.
TBNK
| $500K | 0.01% |
16,170
+2,300
| +17% | +$64.8K |
|
|
ALTA
740
DELISTED
Altabancorp
ALTA
| $496K | 0.01% |
+16,883
| New | +$485K |
|
741
Sutro Biopharma
STRO
$379M
| $494K | 0.01% |
4,337
-16
| -0.4% | -$1.76K |
|
|
MOFG
742
DELISTED
MidWestOne Financial Group
MOFG
| $492K | 0.01% |
17,596
-2,484
| -12% | -$70.3K |
|
743
Puma Biotechnology
PBYI
$406M
| $488K | 0.01% |
38,360
-5,220
| -12% | -$120K |
|
|
FSP
744
Franklin Street Properties
FSP
$44.8M
| $483K | 0.01% |
65,500
-92,218
| -58% | -$699K |
|
|
UNT
745
DELISTED
UNIT Corporation
UNT
| $482K | 0.01% |
+54,200
| New | +$629K |
|
746
Universal Display
OLED
$3.71B
| $478K | 0.01% |
+2,540
| New | +$422K |
|
|
IVAC
747
DELISTED
Intevac Inc
IVAC
| $476K | 0.01% |
98,426
-5,005
| -5% | -$26.2K |
|
|
CNCE
748
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $472K | 0.01% |
+39,300
| New | +$423K |
|
749
The Ensign Group
ENSG
$10.1B
| $471K | 0.01% |
+8,841
| New | +$442K |
|
|
BFIN
750
DELISTED
BankFinancial
BFIN
| $467K | 0.01% |
33,410
+9,710
| +41% | +$141K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q2 2019 Portfolio in Review
As of Q2 2019, Jacobs Levy Equity Management held 1,100 positions worth $7.23B, up 4.3% from $6.93B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Jacobs Levy Equity Management's Q2 2019 filing shows 151 new, 415 increased, 333 reduced and 164 closed positions. Its largest new stake was Biogen: 175,817 shares worth $41.1M. The largest sale was Allergan plc, an estimated $51.9M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
- Jacobs Levy Equity Management's largest Q2 2019 buy was Biogen: 175,817 shares worth $41.1M.
- Jacobs Levy Equity Management added most to Ecolab in Q2 2019, an estimated $35.6M increase.
- Jacobs Levy Equity Management's biggest Q2 2019 reduction was EOG Resources, cutting an estimated $33.8M.
- Jacobs Levy Equity Management fully exited Allergan plc in Q2 2019, selling an estimated $51.9M.
- Jacobs Levy Equity Management's ten largest holdings make up 15% of its $7.23B portfolio in Q2 2019.
- Jacobs Levy Equity Management opened 151 new positions and closed 164 in Q2 2019.
- Jacobs Levy Equity Management's portfolio value rose 4.3% quarter-over-quarter to $7.23B.
Based on Jacobs Levy Equity Management's 13F filing for Q2 2019, filed 13 Aug 2019.